{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:12:41Z","timestamp":1777029161586,"version":"3.51.4"},"reference-count":156,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.arbres.2011.10.007","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T09:52:32Z","timestamp":1324547552000},"page":"86-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Fenotipos cl\u00ednicos de la EPOC. Identificaci\u00f3n, definici\u00f3n e implicaciones para las gu\u00edas de tratamiento"],"prefix":"10.1016","volume":"48","author":[{"given":"Marc","family":"Miravitlles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Calle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Soler-Catalu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2011.10.007_bib0005","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","article-title":"Chronic obstructive pulmonary disease phenotypes. The future of COPD","volume":"182","author":"Han","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0010","first-page":"22","article-title":"Fenotipos de la enfermedad pulmonar obstructiva cr\u00f3nica","volume":"8","author":"Calle Rubio","year":"2007","journal-title":"Med Clin Monogr"},{"key":"10.1016\/j.arbres.2011.10.007_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.arbres.2008.10.001","article-title":"La heterogeneidad fenot\u00edpica de la EPOC","volume":"45","author":"Garcia-Aymerich","year":"2009","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2011.10.007_bib0020","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1378\/chest.124.2.474","article-title":"The proportional Venn diagram of obstructive lung disease","volume":"124","author":"Soriano","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.07-3059","article-title":"The many small COPDs: COPD should be an orphan disease","volume":"134","author":"Rennard","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1164\/rccm.200712-1869OC","article-title":"Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease. Results from the TORCH study","volume":"178","author":"Celli","year":"2008","journal-title":"Am J Respir Crit Care Dis"},{"key":"10.1016\/j.arbres.2011.10.007_bib0035","first-page":"77","article-title":"Standards for diagnosis and care of patients with chronic obstructive pulmonary disease","volume":"152","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0040","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.rmed.2010.04.021","article-title":"Airway dimensions in COPD: Relationship with clinical variables","volume":"104","author":"Mair","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0045","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/thx.2010.154484","article-title":"Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) phenotypes","volume":"66","author":"Garcia-Aymerich","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0050","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1157\/13095974","article-title":"Normativa SEPAR: Diagn\u00f3stico y tratamiento del d\u00e9ficit de alfa-1-antitripsina","volume":"42","author":"Vidal","year":"2006","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2011.10.007_bib0055","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/thx.2008.108027","article-title":"The overlap syndrome of asthma and COPD: What are its features and how important is it?","volume":"64","author":"Gibson","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0060","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.120.6.1917","article-title":"Smoking and airways inflammation in patients with mild asthma","volume":"120","author":"Chalmers","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1378\/chest.129.3.661","article-title":"Smoking and asthma: Clinical and radiological features, lung function, and airway inflammation","volume":"129","author":"Boulet","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1164\/rccm.200603-381OC","article-title":"Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm","volume":"175","author":"De Marco","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0075","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1378\/chest.108.6.1568","article-title":"Inhaled budesonide therapy for patients with stable COPD","volume":"108","author":"Weiner","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0080","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1183\/09031936.06.00072105","article-title":"Stable COPD: Predicting benefit from high-dose inhaled corticosteroid treatment","volume":"27","author":"Leigh","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0085","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/thx.2009.115725","article-title":"Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities","volume":"64","author":"Miravitlles","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0090","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1164\/ajrccm.162.5.9910112","article-title":"Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease","volume":"162","author":"Papi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0095","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1183\/09031936.93.06060868","article-title":"Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled conticosteroid treatment","volume":"6","author":"Kerstjens","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0100","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pupt.2008.04.003","article-title":"Lung function and symptom improvement with fluticasone propionate\/salmeterol and ipratropium bromide\/albuterol in COPD: Response by beta-agonist reversibility","volume":"21","author":"Bleecker","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.arbres.2011.10.007_bib0105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.rmed.2009.10.024","article-title":"Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype","volume":"104","author":"Lee","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/thx.2004.032516","article-title":"Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pumonary disease","volume":"60","author":"Brightling","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1753465808088902","article-title":"Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study","volume":"2","author":"Kunisaki","year":"2008","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.arbres.2011.10.007_bib0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1183\/09031936.00177508","article-title":"Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD","volume":"35","author":"Lehtim\u00e4ki","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0125","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1164\/rccm.200905-0685OC","article-title":"Predicting conrtocosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide","volume":"180","author":"Dummer","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0130","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.rmed.2006.02.003","article-title":"Characteristics of COPD phenotypes classified according to the findings of HRCT","volume":"100","author":"Kitagushi","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0135","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: A randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/COPD.S2999","article-title":"Targeted treatment in COPD: A multi-system approach for a multi-system disease","volume":"4","author":"Anderson","year":"2009","journal-title":"Int J Chron Obst Pulm Dis"},{"key":"10.1016\/j.arbres.2011.10.007_bib0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.arbres.2011.01.016","article-title":"Corticosteroides inhalados en la EPOC por fenotipo en lugar de por gravedad. Argumentos a favor","volume":"47","author":"Miravitlles","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2011.10.007_bib0150","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.2112055","article-title":"Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in the treatment of chronic obstructive pulmonary disease","volume":"166","author":"Mahler","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0155","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1164\/rccm.200602-244OC","article-title":"Impact of salmeterol\/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease","volume":"175","author":"Kardos","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0165","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/thorax.58.8.659","article-title":"Bronchodilator reversibility testing in chronic obstructive pulmonary disease","volume":"58","author":"Calverley","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0170","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000067462","article-title":"Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: A multiple logistic regression analysis","volume":"67","author":"Miravitlles","year":"2000","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2011.10.007_bib0175","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0180","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/15412555.2010.496817","article-title":"Frequent chronic obstructive pulmonary disease exacerbators: How much real, how much fictitious?","volume":"7","author":"Soler-Catalu\u00f1a","year":"2010","journal-title":"COPD"},{"key":"10.1016\/j.arbres.2011.10.007_bib0185","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1056\/NEJMe1008184","article-title":"Frequent exacerbations of chronic obstructive pulmonary disease \u2014 a distinct phenotype?","volume":"363","author":"Tashkin","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0190","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1183\/09031936.00120107","article-title":"Relationship between depression and exacerbations in COPD","volume":"32","author":"Quint","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.rmed.2003.04.001","article-title":"Risk factors of emergency care and admissions in COPD patients with high consumption of health resources","volume":"98","author":"Soler","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0205","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0300-2896(01)78818-7","article-title":"The impact of COPD on hospital resources: The specific burden of COPD patients with high rates of hospitalization","volume":"37","author":"Soler","year":"2001","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2011.10.007_bib0210","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0215","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s11606-008-0783-x","article-title":"Predictors of mortality in patients with stable COPD","volume":"23","author":"Esteban","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0220","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.rmed.2008.12.005","article-title":"Severe exacerbations and BODE index: Two independent risk factors for death in male COPD patients","volume":"103","author":"Soler-Catalu\u00f1a","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1479972310368692","article-title":"The effect of airflow limitation on the cause of death in patients with COPD","volume":"7","author":"Alfageme","year":"2010","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.arbres.2011.10.007_bib0230","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1378\/chest.117.3.662","article-title":"Acute exaerbation of COPD: Factors associated with poor outcome","volume":"117","author":"Dewan","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/thorax.58.2.100","article-title":"Risk factors of readmission to hospital for a COPD exacerbation: a prospective study","volume":"58","author":"Garc\u00eda-Aymerich","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0240","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.06-1316","article-title":"Risk indexes for exacerbations and hospitalizations due to COPD","volume":"131","author":"Niewoehner","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0245","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1378\/chest.08-2062","article-title":"Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects","volume":"135","author":"Burgel","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0250","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/thorax.57.9.759","article-title":"Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations","volume":"57","author":"Patel","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0255","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.rmed.2006.08.020","article-title":"Relationship between airway colonization, inflammation and exacerbation frequency in COPD","volume":"101","author":"Tumkaya","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0260","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.rmed.2010.11.015","article-title":"Clinical predictors of frequent exacerbations in subjets with severe chronic obstructive pulmonary disease (COPD)","volume":"105","author":"Wan","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0265","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1183\/09031936.97.10020417","article-title":"Muscle weakness is related to utilization of health care resources in COPD patients","volume":"10","author":"Decramer","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0270","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1378\/chest.09-2029","article-title":"Increased risk of myocardial infarction and stroke following exacerbation of chronic obstructive pulmonary disease","volume":"137","author":"Donaldson","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0275","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0280","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2006.10.012","article-title":"Exacerbations and lung function decline in COPD: New insights in current and ex-smokers","volume":"101","author":"Makris","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0285","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.rmed.2011.02.003","article-title":"Cough and sputum production as risk factors for poor outcomes in patients with COPD","volume":"105","author":"Miravitlles","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0290","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1183\/09031936.00009307","article-title":"Clinical determinats of exacerbations in severe, early-onset COPD","volume":"30","author":"Foreman","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0295","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1183\/09031936.95.08081333","article-title":"Chronic mucus hypersecretion in COPD and death from pulmonary infection","volume":"8","author":"Prescott","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0300","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Garcia MA, Soler-Catalu\u00f1a JJ, Donat Y, Catal\u00e1n S, Agramunt M, Ballest\u00edn J, et al. Factors associated with bronchiectasis in chronic obstructive pulmonary disease patients. Chest. 2011;140:1130-7.","DOI":"10.1378\/chest.10-1758"},{"key":"10.1016\/j.arbres.2011.10.007_bib0305","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/rccm.200305-648OC","article-title":"Bronchiectasis, exacerbation \u00edndices, and inflammation in chronic obstructive pulmonary disease","volume":"170","author":"Patel","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0310","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/thorax.55.2.114","article-title":"Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations","volume":"55","author":"Bhowmik","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0315","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1465-9921-11-58","article-title":"Colour of sputum is a marker of bacterial colonization in COPD","volume":"11","author":"Miravitlles","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2011.10.007_bib0320","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10096-010-1027-7","article-title":"Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease","volume":"29","author":"Zhang","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Supl 36","key":"10.1016\/j.arbres.2011.10.007_bib0325","doi-asserted-by":"crossref","first-page":"9s","DOI":"10.1183\/09031936.02.00400302","article-title":"Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?","volume":"20","author":"Miravitlles","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0330","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.200703-417OC","article-title":"Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease","volume":"176","author":"Sethi","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0335","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0340","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1183\/09031936.05.00043405","article-title":"Epidemiological relationships between the common cold and exacerbation frequency in COPD","volume":"26","author":"Hurst","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0345","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/thx.2007.092858","article-title":"Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation","volume":"63","author":"Terada","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0350","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1378\/chest.09-0482","article-title":"Abnormal swallowing reflex and COPD exacerbation","volume":"137","author":"Terada","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0355","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/rccm.200603-380OC","article-title":"Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease. Diagnostic performance of cardiac biomarkers","volume":"174","author":"Abroug","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0360","first-page":"212","article-title":"Elevation of cardiac troponins in exacerbation of chronic obstructive pulmonary disease","volume":"16","author":"Harvey","year":"2004","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.arbres.2011.10.007_bib0365","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1378\/chest.08-2918","article-title":"A postmorten analysis of major causes of early death in patients hospitalized with COPD exacerbation","volume":"136","author":"Zvezdin","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0370","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1164\/rccm.200603-443OC","article-title":"A Single nucleotide polymorphism in the CCL1 gene predicts acute exacerbations in chronic obstructive pulmonary disease","volume":"174","author":"Takabatake","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0375","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.gene.6363961","article-title":"Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections","volume":"4","author":"Yang","year":"2003","journal-title":"Genes and Immunity"},{"key":"10.1016\/j.arbres.2011.10.007_bib0380","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000228159","article-title":"Mannose-binding lectin deficiency and respiratory tract infection","volume":"2","author":"Eisen","year":"2010","journal-title":"J Innate Immun"},{"key":"10.1016\/j.arbres.2011.10.007_bib0385","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1183\/09031936.00166606","article-title":"Impact on patients\u2019 health status following early identification of a COPD exacerbation","volume":"30","author":"Bourbeau","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0390","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00019053-200523040-00005","article-title":"Quality of life in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: A review of the literature","volume":"23","author":"Doll","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.arbres.2011.10.007_bib0395","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/thx.2003.008730","article-title":"Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: A 2 year follow up study","volume":"59","author":"Miravitlles","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0400","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1378\/chest.06-1610","article-title":"Impact of COPD exacerbations on patient-centered outcomes","volume":"131","author":"Cote","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0405","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1008378","article-title":"Tiotropium versus salmeterol for the prevention of exacerbations of COPD","volume":"364","author":"Vogelmeier","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0410","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1157\/13119943","article-title":"Gu\u00eda cl\u00ednica SEPAR-ALAT de diagn\u00f3stico y tratamiento de la EPOC","volume":"44","author":"Peces-Barba","year":"2008","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2011.10.007_bib0415","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0420","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1183\/09031936.03.00031402","article-title":"Efficacy and safety of budesonide\/formoterol and formoterol in chronic obstructive pulmonary diseases","volume":"21","author":"Szafransky","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0425","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1164\/rccm.200610-1563OC","article-title":"Effect of 1-year treatment with roflumilast in severe chornic obstructive pulmonary disease","volume":"176","author":"Calverley","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0430","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(09)61252-6","article-title":"Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials","volume":"374","author":"Fabbri","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2011.10.007_bib0435","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.arbres.2009.10.008","article-title":"Utilidad de los macr\u00f3lidos como antiinflamatorios en las enfermedades respiratorias","volume":"46","author":"Sevilla-S\u00e1nchez","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2011.10.007_bib0440","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0445","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1378\/chest.120.3.730","article-title":"Erythromycin and common cold in COPD","volume":"120","author":"Suzuki","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0450","first-page":"449","article-title":"Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations","volume":"6","author":"Pomares","year":"2011","journal-title":"Int J Chron Obst Respir Dis"},{"key":"10.1016\/j.arbres.2011.10.007_bib0455","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0460","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1183\/09031936.00195608","article-title":"Efficacy of moxifloxacin in the treatment of bronchial colonization in COPD","volume":"34","author":"Miravitlles","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0465","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-11-10","article-title":"Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: A randomized controlled trial","volume":"11","author":"Sethi","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2011.10.007_bib0470","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s12325-008-0105-2","article-title":"Tobramycin nebulizaer solution in severe COPD patients colonized with Pseudomonas aeruginosa: Effects on bronchial inflammation","volume":"25","author":"Dal Negro","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.arbres.2011.10.007_bib0475","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1164\/rccm.200510-1677OC","article-title":"Predictors of mortality in patients with emphysema and severe airflow obstruction","volume":"173","author":"Mart\u00ednez","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0480","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1378\/chest.121.5.1434","article-title":"Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD","volume":"121","author":"Nishimura","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0485","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1164\/rccm.200206-583OC","article-title":"Analysis of the factors related to mortality in chronic obstructive pulmonary disease. Role of exercise capacity and health status","volume":"167","author":"Oga","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0490","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1183\/09031936.03.00034603","article-title":"The 6-min walk distance: Change over time and value as a predictor of survival in severe COPD","volume":"23","author":"Pinto-Plata","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0495","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1164\/rccm.200407-867OC","article-title":"Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease","volume":"171","author":"Casanova","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0500","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1034\/j.1399-3003.2000.16b14.x","article-title":"Role of inspiratory capacity on exercise tolerance in COPD patients with and without expiratory flow limitations at rest","volume":"16","author":"D\u00edaz","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0505","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1164\/ajrccm.164.5.2012122","article-title":"Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease","volume":"164","author":"O\u2019Donnell","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0510","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1164\/ajrccm\/147.5.1157","article-title":"Limited contribution of emphysema in advanced chronic obstructive pulmonary disease","volume":"147","author":"Gelb","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.arbres.2011.10.007_bib0515","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thx.49.5.473","article-title":"Lung structure and function in cigarette smokers","volume":"49","author":"Hogg","year":"1994","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0520","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.rmed.2010.10.018","article-title":"Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO","volume":"105","author":"Grydeland","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0525","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1513\/pats.200508-094DO","article-title":"Why does the lung hyperinflation?","volume":"3","author":"Ferguson","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.arbres.2011.10.007_bib0530","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1378\/chest.09-1847","article-title":"Dynamic hyperinflation during daily activities: Does COPD global initiative for chronic obstructive lung disease stage matter?","volume":"137","author":"Hannink","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0535","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1440-1843.2006.00930.x","article-title":"Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography","volume":"11","author":"Fujimoto","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.arbres.2011.10.007_bib0540","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1164\/rccm.200801-059OC","article-title":"Airway wall thickening and emphysema show independente familial aggregation in chronic obstructive pulmonary disease","volume":"178","author":"Patel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0545","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1183\/09031936.00173009","article-title":"Association of COPD candidate genes with computed tomography emphysema and airways phenotypes in severe COPD","volume":"37","author":"Kim","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0550","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1164\/rccm.201002-0151OC","article-title":"Loci identified by genome-wide association studies influence diferente disease-related phenotypes in chronic obstructive pulmonary disease","volume":"182","author":"Pillai","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0555","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1164\/ajrccm\/148.5.1351","article-title":"Exertional breathlessness in patients with chronic airflow limitation: Role of the lung hyperinsuflation","volume":"148","author":"O\u2019Donnell","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.arbres.2011.10.007_bib0560","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/thx.2006.058321","article-title":"Association between markers of emphysema and more severe obstructive chronic pulmonary disease","volume":"61","author":"Boschetto","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0565","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/thx.2008.112433","article-title":"Prediction of the rate of decline in FEV(1) in smokers using quantitative computed tomography","volume":"64","author":"Yuan","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0570","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1378\/chest.09-2836","article-title":"CT scan findings of emphysema predict mortality in COPD","volume":"138","author":"Haruna","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0575","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1164\/rccm.200510-1677OC","article-title":"Predictors of mortality in patients with emphysema and severe airfl ow obstruction","volume":"173","author":"Martinez","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0580","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1164\/rccm.200812-1873OC","article-title":"Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation","volume":"180","author":"Garcia-Rio","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0585","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/thx.2006.060145","article-title":"Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: A population based cohort study","volume":"61","author":"Garcia-Aymerich","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0590","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1183\/09031936.00151707","article-title":"Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD","volume":"32","author":"Vassaux","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0595","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1378\/chest.06-2245","article-title":"Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: An MRI study","volume":"131","author":"J\u00f6rgensen","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0600","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1378\/chest.09-2810","article-title":"Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: Role of hyperinflation","volume":"138","author":"Watz","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0605","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa0808836","article-title":"Percent emphysema, airflow obstruction, and impaired left ventricular filling","volume":"362","author":"Barr","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0610","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.200906-0876OC","article-title":"Mortality in the 4-year trial of Tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease","volume":"180","author":"Celli","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0615","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1183\/09031936.00098307","article-title":"Methodological issues in therapeutic trials of COPD","volume":"31","author":"Suissa","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0620","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.121.4.1042","article-title":"Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation","volume":"121","author":"Newton","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0625","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1183\/09031936.00129607","article-title":"Bronchodilator responsiveness in patients with COPD","volume":"31","author":"Tashkin","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0630","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1164\/rccm.200708-1194OC","article-title":"The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations","volume":"177","author":"Washko","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0635","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1378\/chest.125.1.249","article-title":"The role of long-acting bronchodilators in the management of stable COPD","volume":"125","author":"Tashkin","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0640","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.04.00116004","article-title":"Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD","volume":"23","author":"O\u2019Donnell","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0645","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/thx.2003.019620","article-title":"Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD","volume":"59","author":"Man","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0650","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1183\/09031936.05.00140404","article-title":"Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD","volume":"26","author":"Van Noord","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0655","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1378\/chest.07-2138","article-title":"Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD","volume":"134","author":"Rabe","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0660","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1465-9921-12-18","article-title":"Reduction of exacerbations by the PDE4 inhibitor roflumilast\u2014the importance of definig different subsets of patients with COPD","volume":"12","author":"Rennard","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2011.10.007_bib0665","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMct0804632","article-title":"Pulmonary rehabilitation for management of chronic obstructive pulmonary disease","volume":"360","author":"Casaburi","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0670","doi-asserted-by":"crossref","unstructured":"Mohamed Hoesein FA, Zanen P, Van Ginneken B, Van Klaveren RJ, Lammers JW. Association of the transfer coefficient (Kco) with emphysema progression in male smokers. Eur Respir J. 2011;38:1012-8.","DOI":"10.1183\/09031936.00050711"},{"key":"10.1016\/j.arbres.2011.10.007_bib0675","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1183\/09031936.00056206","article-title":"Densitometry for assessment of effect of lung volume reduction surgery for emphysema","volume":"29","author":"Stolk","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0680","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1148\/radiology.199.3.8638012","article-title":"Pulmonary emphysema: quantitative CT during expiration","volume":"199","author":"Gevenois","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.arbres.2011.10.007_bib0685","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1164\/ajrccm.152.2.7633722","article-title":"Comparison of computed density and macroscopic morphometry in pulmonary emphysema","volume":"152","author":"Gevenois","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0690","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1378\/chest.99.6.1357","article-title":"Expiratory computed tomography for assessment of suspected pulmonary emphysema","volume":"99","author":"Knudson","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2011.10.007_bib0695","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1164\/ajrccm.161.4.9905040","article-title":"Longitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomography","volume":"161","author":"Soejima","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 3","key":"10.1016\/j.arbres.2011.10.007_bib0700","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0300-2896(07)71180-8","article-title":"Evaluaci\u00f3n funcional respiratoria (obstrucci\u00f3n y atrapamiento)","volume":"43","author":"Garc\u00eda R\u00edo","year":"2007","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2011.10.007_bib0705","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1513\/pats.200508-093DO","article-title":"Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease","volume":"3","author":"O\u2019Donnell","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.arbres.2011.10.007_bib0710","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1164\/ajrccm.163.6.2003172","article-title":"Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease","volume":"163","author":"Mar\u00edn","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"Supl 5","key":"10.1016\/j.arbres.2011.10.007_bib0715","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0300-2896(09)72952-7","article-title":"Tratamiento individualizado de la EPOC: Una propuesta de cambio","volume":"45","author":"Miravitlles","year":"2009","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2011.10.007_bib0720","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.arbres.2010.06.003","article-title":"Estrategias de tratamiento en la enfermedad pulmonar obstructiva cr\u00f3nica: una propuesta de sistematizaci\u00f3n","volume":"46","author":"Lopez-Campos","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2011.10.007_bib0725","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arbres.2011.05.008","article-title":"Hacia un nuevo enfoque en el tratamiento de la EPOC. La Gu\u00eda Espa\u00f1ola de la EPOC (GESEPOC)","volume":"47","author":"Grupo de Trabajo de GESEPOC","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2011.10.007_bib0730","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1365-2222.2005.02344.x","article-title":"Multi-dimensional phenotyping: Towards a new taxonomy for airway disease","volume":"35","author":"Wardlaw","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.arbres.2011.10.007_bib0735","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/thx.2006.072777","article-title":"Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease","volume":"62","author":"Makita","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0740","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/thx.2007.089193","article-title":"Proportional Classifications of COPD phenotypes","volume":"63","author":"Marsh","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2011.10.007_bib0745","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rmed.2007.10.019","article-title":"Identification of a predominant COPD phanotype in clinical practice","volume":"102","author":"Pistolesi","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2011.10.007_bib0750","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1183\/09031936.00137006","article-title":"Chronic bronchitis sub-phenotype within COPD: Inflammation in sputum and biopsies","volume":"31","author":"Snoeck-Stroband","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0755","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1183\/09031936.00174408","article-title":"Distinct clinical phenotypes of airways disease defined by cluster analysis","volume":"34","author":"Weatherall","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0760","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1465-9921-10-41","article-title":"COPD phenotype description using principal components analysis","volume":"10","author":"Roy","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2011.10.007_bib0765","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1183\/09031936.00175109","article-title":"Clinical COPD phenotypes: A novel approach using principal component and cluster analyses","volume":"36","author":"Burgel","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2011.10.007_bib0770","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1465-9921-11-30","article-title":"Cluster analysis in severe emphysema subjects using phenotype and genotype data: An exploratory investigation","volume":"11","author":"Cho","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2011.10.007_bib0775","first-page":"1481","article-title":"Three phenotypes of obstructive lung disease in the elderly","volume":"14","author":"Jo","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.arbres.2011.10.007_bib0780","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/COPD.S16646","article-title":"Components of physical capacity in patients with chronic obstructive pulmonary disease: Relationship with phenotypic expression","volume":"6","author":"M\u00e1rquez-Mart\u00edn","year":"2011","journal-title":"Int J Chron Obst Pulm Dis"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289611003425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289611003425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:36:49Z","timestamp":1759531009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289611003425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":156,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0300289611003425"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2011.10.007","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenotipos cl\u00ednicos de la EPOC. Identificaci\u00f3n, definici\u00f3n e implicaciones para las gu\u00edas de tratamiento","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2011.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 SEPAR. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}